Cargando…
BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms
SIMPLE SUMMARY: Approximately 10–20% of pancreatic cancer patients will have a mutation in their DNA, passed on in families, that contributes to the development of their pancreatic cancer. These mutations are important in that they effect the biology of the disease as well as contribute to sensitivi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140002/ https://www.ncbi.nlm.nih.gov/pubmed/35626055 http://dx.doi.org/10.3390/cancers14102453 |